Canakinumab improves patient-reported outcomes in children and adults with autoinflammatory recurrent fever syndromes: results from the CLUSTER trial
SourceClinical and Experimental Rheumatology, 39, 5, (2021), pp. S51-S58
Article / Letter to editor
Display more detailsDisplay less details
Clinical and Experimental Rheumatology
Upload full text
Use your RU credentials (u/z-number and password) to log in with SURFconext to upload a file for processing by the repository team.